Vivan's comprehensive genomics based drug screening technology developed in partnership with Mt Sinai Medical Center. The Personal Discovey Process will identify personalized drug cocktails to target your cancer
TuMatch analyzes the genetic and molecular profile of your tumour to pinpoint the therapies most likely to work for you.
For complex cases, we explore novel treatment combinations, including the use of non-cancer drugs, to maximize your options.
Our current focus is on colorectal, lung, pancreatic, and other gastrointestinal (GI) cancers, ensuring deep expertise and targeted solutions.
Developed through years of clinical research by the Icahn School of Medicine.
Identifies multi-gene mutations in tumors and their resistance to single-drug treatments.
Combines FDA/NICE & investigational drugs